Alzheimer Disease Clinical Trials in Taipei
5 recruitingTaipei, Taiwan
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Alzheimer DiseaseAgitation
Bristol-Myers Squibb600 enrolled241 locationsNCT06937229
Recruiting
Phase 3
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Alzheimer Disease
Bristol-Myers Squibb352 enrolled157 locationsNCT07011732
Recruiting
Phase 3
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
DementiaBrain DiseasesCentral Nervous System Diseases+6 more
Eli Lilly and Company1,500 enrolled141 locationsNCT05508789
Recruiting
Phase 1
Evaluation of the Safety, Tolerability, and Pharmacokinetics of J4 in Healthy Adults
Alzheimer Disease
Academia Sinica, Taiwan76 enrolled1 locationNCT06938763
Recruiting
Phase 2
A Study of Oral EX039 in Subjects with Mild Alzheimer's Disease
Alzheimer Disease
Excelsior120 enrolled1 locationNCT05413655